Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Psychiatry. 2003 Feb;18(1):40-1.

Which neuroleptic would psychiatrists take for themselves or their relatives?

Author information

  • 1Centre of Psychiatry Weissenau, Department of Psychiatry I, University of Ulm, Weingartshofer Street, Ravensburg-Weissenau 88214, Germany. tilman.steinert@zfp-weissenau.de

Abstract

OBJECTIVE:

Psychiatrists should be asked which neuroleptic they would prefer for themselves and their relatives in the case of first manifestation of schizophrenia.

METHOD:

Questionnaires were answered by 66 psychiatrists from 13 different sites in Baden-Wuerttemberg (South West Germany). Only those were included who had treated more than 50 patients with schizophrenia within the last 5 years (n = 54).

RESULTS:

The psychiatrists were experienced with conventional and most of the atypical agents. Fifty-one point nine percent would take olanzapine as first line treatment, 20.4% risperidone, 13.0% quetiapine, 9.3% amisulpride, 3.7% haloperidol and 1.9% perazine. In four cases, different substances were preferred for oneself and relatives.

CONCLUSION:

Most psychiatrists would not take conventional neuroleptics, though 70% of prescriptions for schizophrenic patients have been conventional neuroleptics in Germany in 2000. The preferences among atypicals correspond well with the current prescription practice in Germany.

PMID:
12648897
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk